Vaccinex, Inc. (VCNX) Ownership
VCNX ownership summary
as of October 20, 2026- Institutions
- 39.9% of shares outstanding
- Insiders
- 0.28% of shares outstanding
- Shares outstanding
- 2.7M
- Float
- 1.6M shares available to trade
- Short interest
- 3.71% 62K shares short
- Days to cover
- 1.06 short interest down 44.6% vs prior month
- Institutions 39.91%
- Insiders 0.28%
- Other investors 59.81%
VCNX top institutional holders
14 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Advisor Group Holdings, Inc. | <0.01% | 53 | $36 | — | December 31, 2024 |
| 2 | Barclays PLC | <0.01% | 46 | $32 | +19 (+70.4%) | December 31, 2024 |
| 3 | Royal Bank of Canada | <0.01% | 37 | $25 | −2 (−5.1%) | September 30, 2024 |
| 4 | Capital Advisors, Ltd. LLC | <0.01% | 3 | $2 | — | September 30, 2024 |
| 5 | Wells Fargo & Co | 0.00% | — | — | −2 (−100.0%) | December 31, 2024 |
| 6 | AIGH Capital Management, LLC | 0.00% | — | — | −108,958 (−100.0%) | September 30, 2024 |
| 7 | Tower Research Capital LLC | 0.00% | — | — | −1,883 (−100.0%) | December 31, 2024 |
| 8 | Northern Trust Investments N A | 0.00% | — | — | −80 (−100.0%) | December 31, 2024 |
| 9 | UBS Group AG | 0.00% | — | — | −3,402 (−100.0%) | December 31, 2024 |
| 10 | Group One Trading, LP | 0.00% | — | — | −67 (−100.0%) | December 31, 2024 |
| 11 | Morgan Stanley - Brokerage Accounts | 0.00% | — | — | −4 (−100.0%) | December 31, 2024 |
| 12 | Armistice Capital, LLC | 0.00% | — | — | −164,000 (−100.0%) | December 31, 2024 |
| 13 | Bank of America Corp | 0.00% | — | — | −24 (−100.0%) | December 31, 2024 |
| 14 | Point72 Asset Management, L.P. | 0.00% | — | — | −166,000 (−100.0%) | December 31, 2024 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 14, 1 holders added 19 shares and 11 cut 444K.
VCNX top mutual fund and ETF holders
2 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | SSgA U.S. Total Market Index Strategy | <0.01% | 36 | $25 | +11 (+44.0%) | June 30, 2024 |
| 2 | NT Ext Eq Mkt Indx Fd DC Lending Tier 5 | <0.01% | 11 | $8 | — | September 30, 2024 |
Funds report holdings monthly or quarterly; dates differ by fund.
VCNX insider transactions
latest 5| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2024-08-09 | Albert Friedberg | Buy | $4.51 | 100 | $451 |
| 2024-08-05 | Albert Friedberg | Buy | $4.60 | 3,653 | $16,804 |
| 2024-07-31 | Albert Friedberg | Buy | $6.15 | 200,000 | $1.2M |
| 2024-05-29 | Albert Friedberg | Buy | $4.95 | 957 | $4,737 |
| 2024-04-19 | Albert Friedberg | Buy | $4.73 | 282 | $1,334 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
VCNX shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns VCNX
Institutional investors own 39.9% of Vaccinex's shares and insiders 0.28%. The largest holder is Advisor Group Holdings, Inc. with <0.01% of the shares (53), as of December 31, 2024. Among the top 14 institutions, 1 added shares and 11 reduced their stake in the latest filings. Short interest is 3.71% of the float, or 1.06 days of average trading volume. The share count rose 7,645.0% since 2017.
Related: VCNX analyst forecast, VCNX key metrics. See the VCNX stock overview for the latest quote and news.
VCNX ownership FAQ
Who owns the most Vaccinex stock?
The largest shareholders of Vaccinex are Advisor Group Holdings, Inc. (<0.01%), Barclays PLC (<0.01%), Royal Bank of Canada (<0.01%), Capital Advisors, Ltd. LLC (<0.01%), Wells Fargo & Co (0.00%).
What percentage of Vaccinex is owned by institutions?
Institutions hold 39.9% of Vaccinex's shares outstanding; insiders hold 0.28%.
Which funds own Vaccinex?
The largest fund holders of Vaccinex are SSgA U.S. Total Market Index Strategy (<0.01%), NT Ext Eq Mkt Indx Fd DC Lending Tier 5 (<0.01%).
What is Vaccinex's short interest?
62K shares of Vaccinex were sold short, 3.71% of the float; at the average daily volume it would take 1.06 days to cover.
Are insiders buying or selling Vaccinex?
Of the latest 5 reported insider transactions in Vaccinex (since April 19, 2024), 5 were purchases and 0 were sales.
How many shares of Vaccinex are outstanding?
Vaccinex has 2.7M shares outstanding, of which 1.6M are in the public float.